drugset / Trial / NCT06385002

Effect of Combined Administration of Sevoflurane and Remimazolam on Emergence

NCT06385002

RandomizedParallel-groupTriple-blindOther

Summary

Enhanced recovery after surgery (ERAS) protocols are being explored to improve patient outcomes. The method of inducing anesthesia and maintenance using inhalation anesthetics is common but may delay recovery. Remimazolam, a benzodiazepine-class drug, is noted for its rapid metabolism and fewer hemodynamic changes. Research suggests combining sevoflurane and propofol for anesthesia in adults enhances recovery, while studies in pediatric patients indicate a reduction in emergence agitation with remimazolam. However, the impact of combining sevoflurane and remimazolam on postoperative recovery in adult patients undergoing gynecologic and laparoscopic surgery is not yet studied. The study aims to compare the time to emergence from anesthesia and tracheal extubation between concurrent sevoflurane and remimazolam administration versus sevoflurane alone.

Timeline

Start
2023-07-31
Primary completion
2024-08-31
Completion
2025-06-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Remimazolam Small molecule 1 mg/kg

Indications

No indication recorded.